Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.940
+0.022 (0.75%)
Aug 7, 2026, 12:56 PM CET
Oryzon Genomics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Oryzon Genomics stock has a consensus rating of "Strong Buy" and an average price target of €7.13. The average 1-year stock price forecast is 142.52% higher than the current stock price, while the lowest is €4.20 (+42.86%) and the highest is €12.00 (+308.16%).
Price Target: €7.13 (+142.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Oryzon Genomics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Roth MKM No rating | Roth MKM | Buy Maintains €12.00 | Buy | Maintains | €12.00 | +308.16% | Jul 28, 2026 |
| Maxim Group | Maxim Group | Buy Maintains €8.65 | Buy | Maintains | €8.65 | +194.32% | Jul 28, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains €4.20 | Buy | Maintains | €4.20 | +42.86% | May 25, 2026 |
Financial Forecast
Revenue This Year
n/a
from 12.84M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.12
from -0.04
EPS Next Year
-0.19
from -0.12
EPS and Forward PE are based on non-GAAP adjusted numbers.